These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8128933

  • 1. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment.
    Wheeler DC, Bernard DB.
    Am J Kidney Dis; 1994 Mar; 23(3):331-46. PubMed ID: 8128933
    [Abstract] [Full Text] [Related]

  • 2. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF, St Peter JV, Kasiske BL.
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [Abstract] [Full Text] [Related]

  • 3. Hyperlipidemia in childhood nephrotic syndrome.
    Thabet MA, Salcedo JR, Chan JC.
    Pediatr Nephrol; 1993 Oct; 7(5):559-66. PubMed ID: 8251323
    [Abstract] [Full Text] [Related]

  • 4. Low-density lipoprotein metabolism in the nephrotic syndrome.
    Warwick GL, Caslake MJ, Boulton-Jones JM, Dagen M, Packard CJ, Shepherd J.
    Metabolism; 1990 Feb; 39(2):187-92. PubMed ID: 2299990
    [Abstract] [Full Text] [Related]

  • 5. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND.
    Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
    [Abstract] [Full Text] [Related]

  • 6. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND, Liang KH.
    Circulation; 2004 Jul 27; 110(4):419-25. PubMed ID: 15262831
    [Abstract] [Full Text] [Related]

  • 7. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P.
    Acta Med Croatica; 2001 Jul 27; 55(4-5):177-86. PubMed ID: 12398021
    [Abstract] [Full Text] [Related]

  • 8. Lipid changes in the nephrotic syndrome: new insights into pathomechanisms and treatment.
    D'Amico G.
    Klin Wochenschr; 1991 Sep 03; 69(13):618-22. PubMed ID: 1753684
    [Abstract] [Full Text] [Related]

  • 9. Should hyperlipidemia in children with the nephrotic syndrome be treated?
    Querfeld U.
    Pediatr Nephrol; 1999 Jan 03; 13(1):77-84. PubMed ID: 10100296
    [Abstract] [Full Text] [Related]

  • 10. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM, Vega GL.
    Am J Med; 1989 Nov 03; 87(5N):3N-11N. PubMed ID: 2486542
    [Abstract] [Full Text] [Related]

  • 11. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B, Ollier J, Olmer M.
    Nephrologie; 1992 Nov 03; 13(5):193-9. PubMed ID: 1470293
    [Abstract] [Full Text] [Related]

  • 12. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.
    Vega GL, Grundy SM.
    Kidney Int; 1988 Jun 03; 33(6):1160-8. PubMed ID: 3165483
    [Abstract] [Full Text] [Related]

  • 13. The hyperlipidemia of the nephrotic syndrome.
    Appel GB, Valeri A, Appel AS, Blum C.
    Am J Med; 1989 Nov 03; 87(5N):45N-50N. PubMed ID: 2486547
    [Abstract] [Full Text] [Related]

  • 14. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.
    Wang L, Shearer GC, Budamagunta MS, Voss JC, Molfino A, Kaysen GA.
    Kidney Int; 2012 Nov 03; 82(9):990-9. PubMed ID: 22785171
    [Abstract] [Full Text] [Related]

  • 15. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO, Alaupovic P.
    Am J Nephrol; 1990 Nov 03; 10 Suppl 1():69-75. PubMed ID: 2256478
    [Abstract] [Full Text] [Related]

  • 16. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG, Kaysen GA, Barrett HA, Stellaard F, Gadellaa MM, Voorbij HA, Reijngoud DJ, Rabelink TJ.
    Kidney Int; 1998 Apr 03; 53(4):994-1001. PubMed ID: 9551409
    [Abstract] [Full Text] [Related]

  • 17. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO, Agbedana EO, Kadiri S, Taylor GO.
    Afr J Med Med Sci; 1999 Apr 03; 28(1-2):97-100. PubMed ID: 12953996
    [Abstract] [Full Text] [Related]

  • 18. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA.
    Miner Electrolyte Metab; 1992 Apr 03; 18(2-5):212-6. PubMed ID: 1465061
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P, Lu L, Hu B, Du PF.
    Scand J Clin Lab Invest; 2009 Apr 03; 69(6):680-6. PubMed ID: 19468931
    [Abstract] [Full Text] [Related]

  • 20. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 Apr 03; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.